Dr. Morgan A Seubold, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1022 E Ray Fine Blvd, Ste 4, Roland, OK 74954 Phone: 918-427-3630 Fax: 918-427-3681 |
Bernard Michael Tougas Jr., D.C, P.A.-C Chiropractor Medicare: Medicare Enrolled Practice Location: 205 E Ray Fine Blvd, Roland, OK 74954 Phone: 918-503-6235 |
Okark Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 205 E Ray Fine Blvd, Roland, OK 74954 Phone: 479-522-2201 |
Seubold Family Chiropractic Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 311 4 E Ray Fine Blvd, Suite4, Roland, OK 74954 Phone: 918-427-3630 |
Tougas Chiropractic Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 205 E Ray Fine Blvd, Suite #6, Roland, OK 74954 Phone: 479-696-8697 Fax: 918-398-0637 |
News Archive
A new understanding of the genetic process that can lead to cervical cancer may help improve diagnosis of potentially dangerous lesions for some women, and also raises a warning flag about the use of anti-viral therapies in certain cases - suggesting they could actually trigger the cancer they are trying to cure.
A Johns Hopkins Children's Center study of 2,500 patient records suggests that medical staff fails to check a child's blood pressure a fifth of the time, and is not recognizing what constitutes an abnormal reading in those whose blood pressure they do check.
For over 20 years, CEDRA Corporation, a division of Worldwide Clinical Trials, has been an industry leader in providing Bioanalytical Sciences and Phase I-IIb Clinical Research Services. Operating as a division of Worldwide Clinical Trials over the past three years, today, CEDRA Corporation announces its new company name, Worldwide Clinical Trials Drug Development Solutions.
Genomic Health, Inc. today announced that the company has entered into an exclusive agreement with Palex Medical S.A., one of Europe's leading distributors of medical device and diagnostic services to hospitals, to distribute its Oncotype DX® breast cancer test in Spain and Portugal. The distribution agreement, announced in conjunction with positive data presented today at the 7th European Breast Cancer Conference (EBCC), further expands the global presence of Oncotype DX, providing for increased physician and patient access to this advanced diagnostic test in the European market.
› Verified 4 days ago